CNBC Investing Club

Investing Club: This drug stock's rip-roaring rally was too good not to take some profits

David Ricks, CEO, Eli Lilly
Scott Mlyn | CNBC

More In CNBC Investing Club Newsletter

Wall Street took a close look at Disney and Microsoft. Here's our take
CNBC Investing ClubWall Street took a close look at Disney and Microsoft. Here's our take
Good riddance September: We gauge the damage in the market and get ready for October
CNBC Investing ClubGood riddance September: We gauge the damage in the market and get ready for October
We're upgrading our rating on AbbVie amid a false report on the biopharma's guidance
CNBC Investing ClubWe're upgrading our rating on AbbVie amid a false report on the biopharma's guidance